Clinical Trial Update: Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK) [Phase 3]

View source ↗

Summary

Phase 3 investigator-initiated trial evaluating OC-01 (varenicline) nasal spray for dry eye disease after LASIK completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• OC-01 (varenicline nasal spray)

Snippet

Sponsor: Vance Thompson Vision ND | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED